Mishima, S., Kawazoe, A., Ohta, T., Esaki, T., Kato, T., Shinozaki, E., Taniguchi, H., Komatsu, Y., Fuse, N., Wakabayashi, M., Takakusa, M., Matsuda, S., Tamura, H., Nomura, S., Sato, A., Fujii, S., Nakamura, Y., Yoshino, T. (2025). Phase I/II study of cabozantinib alone or in combination with panitumumab in patients with
            <i>MET</i>
            -amplified metastatic colorectal cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.146